- Home
- ICCT vs ATXI Comparison
ICCT vs ATXI Comparison
Compare ICCT & ATXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCT
- ATXI
- Stock Information
- Founded
- ICCT 1992
- ATXI 2015
- Country
- ICCT United States
- ATXI United States
- Employees
- ICCT N/A
- ATXI N/A
- Industry
- ICCT Computer Software: Prepackaged Software
- ATXI Biotechnology: Pharmaceutical Preparations
- Sector
- ICCT Technology
- ATXI Health Care
- Exchange
- ICCT Nasdaq
- ATXI Nasdaq
- Market Cap
- ICCT 2.9M
- ATXI 3.0M
- IPO Year
- ICCT N/A
- ATXI 2017
- Fundamental
- Price
- ICCT $2.50
- ATXI $1.85
- Analyst Decision
- ICCT
- ATXI
- Analyst Count
- ICCT 0
- ATXI 0
- Target Price
- ICCT N/A
- ATXI N/A
- AVG Volume (30 Days)
- ICCT 142.3K
- ATXI 61.4K
- Earning Date
- ICCT 11-19-2024
- ATXI 11-14-2024
- Dividend Yield
- ICCT N/A
- ATXI N/A
- EPS Growth
- ICCT N/A
- ATXI N/A
- EPS
- ICCT N/A
- ATXI N/A
- Revenue
- ICCT $11,049,477.00
- ATXI N/A
- Revenue This Year
- ICCT N/A
- ATXI N/A
- Revenue Next Year
- ICCT N/A
- ATXI N/A
- P/E Ratio
- ICCT N/A
- ATXI N/A
- Revenue Growth
- ICCT 42.66
- ATXI N/A
- 52 Week Low
- ICCT $2.25
- ATXI $1.60
- 52 Week High
- ICCT $37.40
- ATXI $15.00
- Technical
- Relative Strength Index (RSI)
- ICCT 42.24
- ATXI 47.67
- Support Level
- ICCT $2.25
- ATXI $1.72
- Resistance Level
- ICCT $2.52
- ATXI $2.04
- Average True Range (ATR)
- ICCT 0.19
- ATXI 0.19
- MACD
- ICCT 0.05
- ATXI -0.00
- Stochastic Oscillator
- ICCT 36.23
- ATXI 33.39
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.
About ATXI Avenue Therapeutics Inc.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.